Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 253,484 shares at $18.90 ($4.8M) on 2018-07-19, disclosed to the SEC on 2018-07-23.
Open-market sale of $4.8M KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.90 | 100,000 | $1.9M | 39.3% |
| 2 | $18.90 | 100,000 | $1.9M | 39.3% |
| 3 | $19.21 | 26,742 | $514K | 10.7% |
| 4 | $19.21 | 26,742 | $514K | 10.7% |
| Total | $18.97 avg | 253,484 | $4.8M | 100% |
| Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |
| KPTI | SELL | 2016-05-12 | $362K | — | Filing → |